
Applied Genetic Technologies Corporation AGTC
Quartalsbericht 2022-Q3
hinzugefügt 21.11.2022
Applied Genetic Technologies Corporation Anteile 2011-2026 | AGTC
Anteile Jährlich Applied Genetic Technologies Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 45 M | 32.8 M | 21.1 M | 18.2 M | 18.1 M | 18.1 M | 17.8 M | 16.3 M | 3.57 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 45 M | 3.57 M | 21.2 M |
Anteile Vierteljährlich Applied Genetic Technologies Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 64.9 M | 51 M | 43.6 M | 42.9 M | 42.8 M | 42.9 M | 36.8 M | 25.9 M | 25.8 M | 25.9 M | 25.8 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.1 M | 18.1 M | 18.2 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 18 M | 18.1 M | 18 M | 18 M | 17.2 M | 18 M | 16.5 M | 16.4 M | 15.6 M | 16 M | 15.6 M | 109 K | 109 K | 109 K | 109 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 64.9 M | 109 K | 21.8 M |
Anteile anderer Aktien in der Pharmaeinzelhändler
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | ||
|
AbbVie
ABBV
|
1.77 B | $ 232.08 | 3.29 % | $ 411 B | ||
|
AbCellera Biologics
ABCL
|
299 M | $ 3.61 | 0.56 % | $ 1.08 B | ||
|
Abeona Therapeutics
ABEO
|
21.4 M | $ 5.12 | -1.54 % | $ 109 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
166 M | $ 4.66 | -0.85 % | $ 773 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
166 M | $ 24.56 | -0.32 % | $ 4.07 B | ||
|
I-Mab
IMAB
|
187 M | - | - | $ 866 M | ||
|
Achieve Life Sciences
ACHV
|
19.8 M | $ 4.56 | -3.59 % | $ 90.4 M | ||
|
AC Immune SA
ACIU
|
75 M | $ 2.93 | -1.01 % | $ 229 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | ||
|
Aclaris Therapeutics
ACRS
|
123 M | $ 2.87 | -8.31 % | $ 352 M | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
Adagene
ADAG
|
56.3 M | $ 2.96 | -4.67 % | $ 167 M | ||
|
ADC Therapeutics SA
ADCT
|
76.7 M | $ 4.1 | -0.73 % | $ 105 M | ||
|
Adial Pharmaceuticals
ADIL
|
6.47 M | $ 2.53 | - | $ 16.4 M | ||
|
ADMA Biologics
ADMA
|
238 M | $ 15.57 | 2.57 % | $ 3.71 B | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
152 M | $ 16.02 | -2.67 % | $ 2.43 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
ADiTx Therapeutics
ADTX
|
13.2 K | $ 0.46 | -4.63 % | $ 6.06 K | ||
|
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | ||
|
Agenus
AGEN
|
358 K | $ 3.33 | -0.89 % | $ 1.19 M | ||
|
Agios Pharmaceuticals
AGIO
|
58 M | $ 30.23 | 0.83 % | $ 1.75 B | ||
|
AIM ImmunoTech
AIM
|
48.1 M | $ 0.91 | -8.59 % | $ 43.8 M | ||
|
Akebia Therapeutics
AKBA
|
257 M | $ 1.31 | -0.76 % | $ 337 M | ||
|
Akari Therapeutics, Plc
AKTX
|
23.9 B | $ 0.24 | -8.87 % | $ 5.73 B | ||
|
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | ||
|
Aldeyra Therapeutics
ALDX
|
60.1 M | $ 5.46 | -0.73 % | $ 328 M | ||
|
Alector
ALEC
|
103 M | $ 2.43 | -5.08 % | $ 250 M | ||
|
Aligos Therapeutics
ALGS
|
64.3 M | $ 7.03 | -6.27 % | $ 452 M | ||
|
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | ||
|
Alkermes plc
ALKS
|
165 M | $ 30.1 | -2.05 % | $ 4.96 B | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
Allogene Therapeutics
ALLO
|
157 M | $ 2.78 | 1.83 % | $ 436 M | ||
|
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
131 M | $ 332.92 | 0.51 % | $ 43.6 B | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
Altimmune
ALT
|
71 M | $ 4.31 | -3.36 % | $ 306 M | ||
|
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | ||
|
ALX Oncology Holdings
ALXO
|
52.2 M | $ 2.11 | -10.21 % | $ 110 M | ||
|
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | ||
|
Amgen
AMGN
|
538 M | $ 388.16 | 2.33 % | $ 209 B | ||
|
Aileron Therapeutics
ALRN
|
17.9 M | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M |